Navigation Links
Researchers awarded $3.2 million from NIH to pioneer advanced biomolecule discovery technology
Date:11/28/2011

(Santa Barbara, Calif.) The National Institutes of Health (NIH) has awarded $3.2 million to a team of preeminent engineering, chemistry, and biology researchers to develop a highly efficient system of generating nucleic acid molecules, called aptamers. The technology provides an entirely new method of discovering and mass producing new high-performance aptamers for a broad range of applications, including next-generation disease diagnosis at the point of care.

Their system, called Quantitative Parallel Aptamer Selection System (QPASS), is a high-throughput screening (HTS) process that will pave the way to develop "instant diagnosis" devices, such as those that detect infectious disease or genetically test a person's response to cancer drugs.

"Our technology is the first step toward devices that could instantly test for HIV or H1N1 in the field or at the bedside, instead of wasting critical time and money waiting for results," said Tom Soh, professor of mechanical engineering and materials, and Co-Director of the Center for Stem Cell Biology and Engineering at UC Santa Barbara. Earlier this year, Soh and his colleagues at UCSB announced the design of a disposable chip that rapidly detects microbes, called a MIMED device. This new aptamer synthesis technology aims to make devices like MIMED chips ready for widespread clinical use.

According to the research team, QPASS solves aptamer discovery problems that have plagued the field for more than 20 years, such as an expensive and lengthy process, and stability of the molecules at room temperature.

"We are developing innovative new technologies that make each step of our process several orders of magnitude more efficient," added Soh. "QPASS will generate high-performance synthetic affinity reagents in a massively parallel manner to meet a growing need in labs and clinics."

Renowned biomedical researchers James Thomson and Lloyd Smith are collaborating with Soh to develop the three novel technologies that comprise QPASS aptamer selection, sequencing, and validation.

Soh is engineering a screening tool that uses microfluidics technology to find the best aptamer sequences among trillions. Thomson, who is world-renowned for his stem cell research, has designed a way to integrate sequencing with selection, using computer algorithms to quickly identify the most promising sequences. Smith's microarray research uses an innovative imaging technology called Surface Plasmon Resonance Imaging or SPRi in combination with a microscopic DNA chip that can validate 10,000 times more sequences than current practices, identifying the most effective aptamers instantly.

"I am delighted to have the opportunity to work with this outstanding team of scientists," said James Thomson, Co-Director of the Center for Stem Cell Biology and Engineering at UCSB, and Director of Regenerative Biology at the Morgridge Institute for Research in Wisconsin. "This grant will strengthen the continuing collaborative efforts between UC Santa Barbara, the Morgridge Institute, and University of Wisconsin-Madison, bringing together leading edge technologies and experts from different disciplines."

"This is an exciting project to address a major barrier to progress in biological research: the lack of effective reagents to specifically bind to target proteins that play central roles in cell biology," said Lloyd Smith, professor of chemistry at University of Wisconsin, Madison, and Director of the Genome Center of Wisconsin.

"There is a new paradigm in medicine called theranostics, or point-of-care testing of a patient's reaction to a medication," explained Soh. "They've just started doing this in larger research hospitals, and to great effect. I believe our integrated technology will someday allow a technician in a small clinic to make a quick diagnosis. Making it affordable for everyone to use is really the value that engineers can provide."

Their research is supported by the Institute of Collaborative Biotechnologies at UCSB.


'/>"/>

Contact: Melissa Van De Werfhorst
melissa@engineering.ucsb.edu
805-893-4301
University of California - Santa Barbara
Source:Eurekalert  

Related biology news :

1. 3 researchers in the Amazon clear up doubts as to the benefits of ecotourism
2. Effects of climate change to further degrade fisheries resources: UBC researchers
3. UGA researchers develop super yeast that turns pine into ethanol
4. Smart swarms of bacteria inspire robotics researchers
5. Finnish researchers discover regulator of human cell activity
6. USC researchers discover key aspect of process that activates breast cancer genes
7. Researchers confirm new cancer-causing virus
8. Researchers get $7.5M grant to combat nerve agents
9. Researchers uncover why the body cant defend against tuberculosis
10. Results triple researchers projections with use of adult stem cells for heart failure
11. Researchers develop more effective way to discover and test potential cancer drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers awarded $3.2 million from NIH to pioneer advanced biomolecule discovery technology
(Date:2/3/2016)... , February 3, 2016 ... market research report "Automated Fingerprint Identification System Market by ... Search), Application (Banking & Finance, Government, Healthcare, and Transportation) ... MarketsandMarkets, the market is expected to be worth USD ... 21.0% between 2015 and 2020. The transformation and technology ...
(Date:2/2/2016)... 2016  BioMEMS devices deployed in hospitals ... medical screening and diagnostic applications, such as ... that facilitate and assure continuous monitoring without ... being bolstered through new opportunities offered by ... coupled with wireless connectivity and low power ...
(Date:2/2/2016)... YORK , Feb. 2, 2016 Technology Enhancements ... presents an analysis of the digital and computed radiography ... Malaysia , and Indonesia ... trends and market size, as well as regional market ... country and discusses market penetration and market attractiveness, both ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... LEXINGTON, Massachusetts , February 4, 2016 - New ... --> - New FDA action date of July ... date of July 22, 2016   - ... the U.S. in the past decade indicated for the treatment of signs and ... Lifitegrast has the potential to be the only product approved in the ...
(Date:2/4/2016)... 4, 2016  CytoSorbents Corporation (NASDAQ: CTSO ... flagship CytoSorb® blood filter to treat deadly inflammation ... world, announced that CEO Dr. Phillip Chan ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... Conference Presentation Details: Where: Convene ...
(Date:2/4/2016)... Feb. 4, 2016 Sinovac Biotech Ltd. ("Sinovac" ... provider of biopharmaceutical products in China ... board of directors received on February 4, 2016 a ... a consortium comprised of PKU V-Ming ( Shanghai ... Ltd., CICC Qianhai Development ( Shenzhen ) ...
(Date:2/3/2016)... 2016  Discovery Laboratories, Inc. (NASDAQ: DSCO ... KL4 surfactant therapies for respiratory diseases, today announced ... inducement award as a component of employment compensation ... President and Chief Executive Officer.  The award was ... 1, 2016 and granted as an inducement material ...
Breaking Biology Technology: